课题基金 / 基金详情

Bifunctional non-secosteroidal vitamin D analogues as novel cancer therapeutics

Bifunctional non-secosteroidal vitamin D analogues as novel cancer therapeutics
双功能非甾体维生素 D 类似物作为新型癌症治疗药物
批准号：
358624
负责人：
Gleason James L
金额：
$29.26万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-10-01 至 2019-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=358624&lang=en
关键词：
Cancer Histone Deacetylases Hybrid Molecules Vitamin D Xenograft Models

项目摘要

项目成果

Gleason James L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have developed a novel class of molecules as potential cancer therapeutics that possess two distinct but complementary biochemical (or drug) activities within a single molecular backbone - essentially acting as two drugs in one. We previously found tha
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of 14-3-3 protein/protein interaction agonists as potential therapies for spinal cord injury and stroke
  • 批准号：
    409940
  • 项目类别：
    Operating Grants
  • 资助金额：
    $20.9万
  • 财政年份：
    2019
  • 负责人：
    Gleason James L
  • 依托单位：
    McGill University
Novel bivalent hybrid molecules with retinoic acid receptor agonistic and histone deacetylase inhibitory activity for cancer treatment
  • 批准号：
    226244
  • 项目类别：
    Operating Grants
  • 资助金额：
    $25.85万
  • 财政年份：
    2011
  • 负责人：
    Gleason James L
  • 依托单位：
    McGill University
海外基金